Information for the public
About infliximab
About infliximab
Infliximab is a type of immunosuppressant, which is given by injection. It stops inflammation by acting on a substance in the body called tumour necrosis factor (TNF) alpha.
Infliximab is licensed in the UK for treating severe flare-ups of the following diseases:
-
rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, in which the joints are inflamed
-
Crohn's disease and ulcerative colitis, in which the digestive system is inflamed
-
psoriasis, in which the skin is inflamed.
Infliximab is sometimes used to treat sarcoidosis but it isn't licensed in the UK for this. Use in this way is therefore off-label.